Broadenbio Ltd., Co.
Broadenbio Ltd., Co.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Not yet recruiting | Phase 2 | 2025-11-20 | NCT07239986 | |
| A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2025-11-17 | NCT06258408 | |
| A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors | Advanced Solid Tumor | Active, not recruiting | Phase 1 | 2025-11-17 | NCT06143007 |